566 related articles for article (PubMed ID: 31477476)
1. Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study.
Salem JE; Bretagne M; Lebrun-Vignes B; Waintraub X; Gandjbakhch E; Hidden-Lucet F; Gougis P; Bachelot A; Funck-Brentano C;
Arch Cardiovasc Dis; 2019 Nov; 112(11):699-712. PubMed ID: 31477476
[TBL] [Abstract][Full Text] [Related]
2. Hypogonadism as a Reversible Cause of Torsades de Pointes in Men.
Salem JE; Waintraub X; Courtillot C; Shaffer CM; Gandjbakhch E; Maupain C; Moslehi JJ; Badilini F; Haroche J; Gougis P; Fressart V; Glazer AM; Hidden-Lucet F; Touraine P; Lebrun-Vignes B; Roden DM; Bachelot A; Funck-Brentano C
Circulation; 2018 Jul; 138(1):110-113. PubMed ID: 29967236
[No Abstract] [Full Text] [Related]
3. Androgenic Effects on Ventricular Repolarization: A Translational Study From the International Pharmacovigilance Database to iPSC-Cardiomyocytes.
Salem JE; Yang T; Moslehi JJ; Waintraub X; Gandjbakhch E; Bachelot A; Hidden-Lucet F; Hulot JS; Knollmann BC; Lebrun-Vignes B; Funck-Brentano C; Glazer AM; Roden DM
Circulation; 2019 Sep; 140(13):1070-1080. PubMed ID: 31378084
[TBL] [Abstract][Full Text] [Related]
4. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation.
Kirchhof P; Franz MR; Bardai A; Wilde AM
J Am Coll Cardiol; 2009 Jul; 54(2):143-9. PubMed ID: 19573731
[TBL] [Abstract][Full Text] [Related]
5. Transient Hypogonadism Is Associated With Heart Rate-Corrected QT Prolongation and Torsades de Pointes Risk During Active Systemic Inflammation in Men.
Lazzerini PE; Cantara S; Bertolozzi I; Accioli R; Salvini V; Cartocci A; D'Errico A; Sestini F; Bisogno S; Cevenini G; Capecchi M; Laghi-Pasini F; Castagna MG; Acampa M; Boutjdir M; Capecchi PL
J Am Heart Assoc; 2022 Jan; 11(1):e023371. PubMed ID: 34935398
[TBL] [Abstract][Full Text] [Related]
6. Androgenic effects on ventricular repolarization: A translational study from the international pharmacovigilance database to iPSC-cardiomyocytes.
Salem JE; Yang T; Moslehi JJ; Waintraub X; Gandjbakhch E; Bachelot A; Hidden-Lucet F; Hulot JS; Knollmann BC; Lebrun-Vignes B; Funck-Brentano C; Glazer AM; Roden DM
Ann Endocrinol (Paris); 2021 Jun; 82(3-4):132-133. PubMed ID: 32171470
[TBL] [Abstract][Full Text] [Related]
7. Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes.
Lazzerini PE; Laghi-Pasini F; Bertolozzi I; Morozzi G; Lorenzini S; Simpatico A; Selvi E; Bacarelli MR; Finizola F; Vanni F; Lazaro D; Aromolaran A; El Sherif N; Boutjdir M; Capecchi PL
Heart; 2017 Nov; 103(22):1821-1829. PubMed ID: 28490617
[TBL] [Abstract][Full Text] [Related]
8. Increased long QT and torsade de pointes reporting on tamoxifen compared with aromatase inhibitors.
Grouthier V; Lebrun-Vignes B; Glazer AM; Touraine P; Funck-Brentano C; Pariente A; Courtillot C; Bachelot A; Roden DM; Moslehi JJ; Salem JE
Heart; 2018 Nov; 104(22):1859-1863. PubMed ID: 29720397
[TBL] [Abstract][Full Text] [Related]
9. Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome.
Darbar D; Kimbrough J; Jawaid A; McCray R; Ritchie MD; Roden DM
J Am Coll Cardiol; 2008 Feb; 51(8):836-42. PubMed ID: 18294569
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Microvolt T-Wave Alternans in Patients With Long QT Syndrome and Its Association With Torsade de Pointes.
Takasugi N; Goto H; Takasugi M; Verrier RL; Kuwahara T; Kubota T; Toyoshi H; Nakashima T; Kawasaki M; Nishigaki K; Minatoguchi S
Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003206. PubMed ID: 26839386
[TBL] [Abstract][Full Text] [Related]
11. Citalopram induced torsade de pointes, a rare life threatening side effect.
Kanjanauthai S; Kanluen T; Chareonthaitawee P
Int J Cardiol; 2008 Dec; 131(1):e33-4. PubMed ID: 17919753
[TBL] [Abstract][Full Text] [Related]
12. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of symptomatic drug-induced long QT syndrome and Torsade de Pointes in Germany.
Sarganas G; Garbe E; Klimpel A; Hering RC; Bronder E; Haverkamp W
Europace; 2014 Jan; 16(1):101-8. PubMed ID: 23833046
[TBL] [Abstract][Full Text] [Related]
14. Evaluation and Management of Athletes With Long QT Syndrome.
Gomez AT; Prutkin JM; Rao AL
Sports Health; 2016; 8(6):527-535. PubMed ID: 27480102
[TBL] [Abstract][Full Text] [Related]
15. Influence of steroid hormones on ventricular repolarization.
Salem JE; Alexandre J; Bachelot A; Funck-Brentano C
Pharmacol Ther; 2016 Nov; 167():38-47. PubMed ID: 27452340
[TBL] [Abstract][Full Text] [Related]
16. Electrocardiographic Parameters Indicating Worse Evolution in Patients with Acquired Long QT Syndrome and Torsades de Pointes.
Kukla P; Jastrzębski M; Fijorek K; Stec S; Bryniarski L; Czarnecka D; Baranchuk A
Ann Noninvasive Electrocardiol; 2016 Nov; 21(6):572-579. PubMed ID: 27018992
[TBL] [Abstract][Full Text] [Related]
17. Fragmented QRS is associated with torsades de pointes in patients with acquired long QT syndrome.
Haraoka K; Morita H; Saito Y; Toh N; Miyoshi T; Nishii N; Nagase S; Nakamura K; Kohno K; Kusano KF; Kawaguchi K; Ohe T; Ito H
Heart Rhythm; 2010 Dec; 7(12):1808-14. PubMed ID: 20837161
[TBL] [Abstract][Full Text] [Related]
18. Acquired long QT syndrome and torsade de pointes.
El-Sherif N; Turitto G; Boutjdir M
Pacing Clin Electrophysiol; 2018 Apr; 41(4):414-421. PubMed ID: 29405316
[TBL] [Abstract][Full Text] [Related]
19. QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France.
Perrin-Terrin A; Pathak A; Lapeyre-Mestre M
Fundam Clin Pharmacol; 2011 Aug; 25(4):503-10. PubMed ID: 20825488
[TBL] [Abstract][Full Text] [Related]
20. Acquired long QT syndrome from stress cardiomyopathy is associated with ventricular arrhythmias and torsades de pointes.
Madias C; Fitzgibbons TP; Alsheikh-Ali AA; Bouchard JL; Kalsmith B; Garlitski AC; Tighe DA; Estes NA; Aurigemma GP; Link MS
Heart Rhythm; 2011 Apr; 8(4):555-61. PubMed ID: 21146632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
